Louisa Daniels leaves Pfizer to become Recursion chief legal officer
Recursion, a biotechnology company scaling more like a technology company, announced the appointment of Louisa Daniels (pictured) as its Chief Legal Officer and General Counsel. In her new role, Daniels will oversee Recursion’s legal and compliance functions and augment Recursion’s industry-leading executive team.
With more than 20 years in senior roles in the biopharma industry, Daniels joins Recursion from Pfizer, where she served as Vice President & Assistant General Counsel. In that position, Daniels was head of the clinical development legal team and had a leading role in legal support for Pfizer’s Covid-19 vaccine program, Operation Light Speed.
Overall, in Pfizer she served as Vice President & Assistant General Counsel from April 2008 to January 2021 and also as Chief Counsel of Global Product Development from May 2016 to January 2021. Previously she was Chief Counsel of Global Commercial Operations, Strategy & Portfolio Management from 2013 to 2016 and served as Lead Counsel of PharmaTherapeutics R&D from 2008 to 2013.